| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/13/2006 | WO2006038608A1 Oligo double-stranded rna and medicinal composition |
| 04/13/2006 | WO2006038172A1 New piperidine antibiotics |
| 04/13/2006 | WO2006038116A2 Triazolopyridine derivatives as antibacterial agents |
| 04/13/2006 | WO2006038115A1 Multivalent canine vaccines against leptospira bratislava and other pathogens |
| 04/13/2006 | WO2006038100A1 Oxazolidinone derivatives as antimicrobials |
| 04/13/2006 | WO2006038088A1 Use of [d-meala]3-[etval]4-cyclosporin for the treatment of hepatitis c infection and pharmaceutical composition comprising said [d-meala]3-[etval]4-cyclosporin |
| 04/13/2006 | WO2006038039A1 Modulators of hcv replication |
| 04/13/2006 | WO2006037468A1 Hiv reverse transcriptase inhibitors |
| 04/13/2006 | WO2006037452A1 NOVEL USE OF α-SYMPATHOMIMETICS HAVING A 2-IMIDAZOLINE STRUCTURE |
| 04/13/2006 | WO2006037185A1 Novel sulfenamides and sulfenamide oxides |
| 04/13/2006 | WO2006024770A3 Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 04/13/2006 | WO2006018185A3 Dihydropteridinones for the treatment of cancer diseases |
| 04/13/2006 | WO2006006074A3 Inhibitors based on fusion, hr1 and hr2 sequences in bacterial adhesin |
| 04/13/2006 | WO2005122791A3 Improvement of barrier integrity in hiv patients with fatty acids |
| 04/13/2006 | WO2002038576A1 ARYL PHOSPHATE DERIVATIVES OF d4T |
| 04/13/2006 | US20060079695 Antibacterial oxalidinones |
| 04/13/2006 | US20060079670 98 human secreted proteins |
| 04/13/2006 | US20060079577 Lipoxins and aspirin-triggered lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases |
| 04/13/2006 | US20060079546 Aminopiperidine derivatives as antibacterials |
| 04/13/2006 | US20060079525 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis |
| 04/13/2006 | US20060079503 Thiazolidinones and the use therof as polo-like kinase inhibitors |
| 04/13/2006 | US20060079440 Treatment of hi-virus infections with oxidised blood proteins |
| 04/13/2006 | US20060078980 Production of polyketides and other natural products |
| 04/13/2006 | US20060078918 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator |
| 04/13/2006 | US20060078901 Listeria monocytogenes genome, polypeptides and uses |
| 04/13/2006 | US20060078878 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |
| 04/13/2006 | US20060078629 Nutritional compositions and use thereof |
| 04/13/2006 | US20060078595 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 04/13/2006 | US20060078582 Use of compositions for treating rosacea |
| 04/13/2006 | US20060078547 Lactobacillus salivarius strain, AH102, AH103, AH105, AH109 or AH110 or mutants or variants are useful in the prophylaxis and/or treatment undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome |
| 04/13/2006 | US20060078537 Mono-and dual chemokine/cytokine constructs |
| 04/13/2006 | DE10320633B4 Verfahren zur Identifizierung einer möglichen Modifikation von mindestens einem biologischen Parameter unter Verwendung von lebenden Zellen, die einem Reiz ausgesetzt wurden, und lebenden Zellen, die nicht diesem Reiz ausgesetzt wurden A method of identifying a possible modification of at least one biological parameter using living cells that were exposed to a stimulus, and living cells that were not exposed to this stimulus |
| 04/13/2006 | DE10021433B4 Verfahren zur Herstellung eines antiviralen Mittels Process for the preparation of an antiviral agent |
| 04/13/2006 | CA2583689A1 Multivalent canine vaccines against leptospira bratislava and other pathogens |
| 04/13/2006 | CA2583351A1 Combination anti-viral compositions comprising castanospermine and methods of use |
| 04/13/2006 | CA2583061A1 Antibody production method |
| 04/13/2006 | CA2582760A1 Modulators of hcv replication |
| 04/13/2006 | CA2582482A1 Triazolopyridine derivatives as antibacterial agents |
| 04/13/2006 | CA2581057A1 New piperidine antibiotics |
| 04/13/2006 | CA2562151A1 Oligonucleotides comprising a c5-modified pyrimidine |
| 04/12/2006 | EP1645635A2 Replication defective recombinant retroviruses expressing a palliative |
| 04/12/2006 | EP1645631A2 Neisseria antigens and compositions |
| 04/12/2006 | EP1645624A1 Nerve cells obtained by electrical pulse treatment es cell |
| 04/12/2006 | EP1645567A1 Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
| 04/12/2006 | EP1645288A1 New nuclear transcription factors regulators |
| 04/12/2006 | EP1645287A2 Anhydrous topical skin preparations |
| 04/12/2006 | EP1645284A1 Use of ligands of the antigen CDw52 for the treatment of diseases that are related to degenerated macrophages |
| 04/12/2006 | EP1645279A1 Agent for inhibiting membrane virus reproduction, method for the production thereof, pharmaceutical composition and method for inhibiting viral infections |
| 04/12/2006 | EP1644414A2 Binding molecules against sars-coronavirus and uses thereof |
| 04/12/2006 | EP1644410A1 Sushi peptide multimer |
| 04/12/2006 | EP1644404A2 Antigenic peptides of sars coronavirus and uses thereof |
| 04/12/2006 | EP1644389A1 Pyrimidine compounds having phosphonate groups as antiviral nucleotide analogs |
| 04/12/2006 | EP1644385A1 Silicon compounds and their use |
| 04/12/2006 | EP1644382A2 Cross-linked glycopeptide-cephalosporin antibiotics |
| 04/12/2006 | EP1644040A1 Use of combinations of reverse transcriptase inhibitors and virus coded dna polymerase inhibitors |
| 04/12/2006 | EP1644036A2 Immunization method against neisseria meningitidis serogroups a and c |
| 04/12/2006 | EP1644010A2 Colloidal silver composition having antimicrobial properties |
| 04/12/2006 | EP1644009A2 Compositions and methods for increasing telomerase activity |
| 04/12/2006 | EP1643971A2 Liposomal formulations comprising a combination of two or more active agents |
| 04/12/2006 | EP1643947A2 Delivery system for topical medications |
| 04/12/2006 | EP1643865A1 Nutritional compositions and use thereof |
| 04/12/2006 | EP1542988B1 Piperidine quinolyl propyl derivatives, preparation method and intermediates and compositions containing same |
| 04/12/2006 | EP1446403B1 Aryl substituted oxazolidinones with antibacterial activity |
| 04/12/2006 | EP1404174A4 Anti-infective compositions for treating disordered tissue such as cold sores |
| 04/12/2006 | EP1401828B1 N-formyl hydroxylamine compounds as inhibitors of pdf |
| 04/12/2006 | EP1345920B1 Novel sulfamides and their use as endothelin receptor antagonists |
| 04/12/2006 | EP1299416B1 Antifungal and/or antibacterial peptides, preparation methods and composition containing same |
| 04/12/2006 | EP1270017B1 Radiolabeled pyrimidine nucleoside for the diagnosis of tissue-reproductive activity |
| 04/12/2006 | EP1254119B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 04/12/2006 | EP1194156B1 Dietary supplement for treating malignancies and viral infections and improving immune function |
| 04/12/2006 | EP1192247B1 Sphingosine kinase enzyme |
| 04/12/2006 | EP1118659B1 Expression systems for functional nucleic acid expression |
| 04/12/2006 | EP1075261B1 Mycobacterial inhibitors |
| 04/12/2006 | EP1054887B1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists |
| 04/12/2006 | EP1005356B1 Novel antibacterial agents |
| 04/12/2006 | EP0985046B1 Recombinant poxvirus incapable of expressing a41l gene, coding for a soluble protein that binds chemokines |
| 04/12/2006 | EP0938328B1 Method of inhibiting fibrosis with a somatostatin agonist |
| 04/12/2006 | EP0843549B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor |
| 04/12/2006 | CN2770654Y Direct-administering stick |
| 04/12/2006 | CN1759117A Pyrrolopyridazine derivatives |
| 04/12/2006 | CN1759104A Non-nucleoside reverse transcriptase inhibitors I for treating HIV mediated diseases |
| 04/12/2006 | CN1759103A Water-soluble phenylpyridazine derivative and medicine containing the same |
| 04/12/2006 | CN1759097A Chemical process for the preparation of intermediates to obtain N-formyl hydroxylamine compounds |
| 04/12/2006 | CN1758923A Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria, and methods of use thereof |
| 04/12/2006 | CN1758919A Compositions comprising hyaluronic acid for the prevention of urogenital infections |
| 04/12/2006 | CN1758905A Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections |
| 04/12/2006 | CN1757394A Multi-unit slow-release preparation |
| 04/12/2006 | CN1757393A Fosfocina calcium disperser, and its prepn. method |
| 04/12/2006 | CN1757392A Cream for treating dexmatosis, and its prepn. method |
| 04/12/2006 | CN1757391A Application of neutral berberine sulfate for preparing medicine to treat and prepvent endotoxic diseases |
| 04/12/2006 | CN1757388A Multi-unit slow-releasing preparation |
| 04/12/2006 | CN1250732C 病毒株 Strains |
| 04/12/2006 | CN1250731C Packaging of positive-strand RNA virus replicon particles |
| 04/12/2006 | CN1250725C Prodn of attenuated parainfluenza virus vaccines from cloned nucleotide sequences |
| 04/12/2006 | CN1250717C Human Enzymes of metalloprotease family |
| 04/12/2006 | CN1250563C Androgen glycosides and androgenic activity thereof |
| 04/12/2006 | CN1250551C Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 04/12/2006 | CN1250548C Novel adenine derivatives |
| 04/12/2006 | CN1250544C Pyridoarylphenyl oxazolidinone antibacterials and related compositions and methods |
| 04/12/2006 | CN1250529C Rosinyl acridine its producing method and use thereof |